Rethinking the Build vs Buy Model in Radiopharmaceutical Manufacturing
This session will feature an expert-delivered presentation, before opening to a facilitated audience discussion
- Comparing in-house manufacturing vs CDMO reliance in the context of radiopharmaceutical complexity
- Exploring strategies for combining internal capabilities with strategic CDMO partnerships to ensure continuity of supply while maintaining flexibility
- Evaluating how facility decisions impact control, flexibility, and scalability across the supply chain
- Identifying hidden constraints beyond infrastructure, particularly workforce availability and expertise